THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA